Q1 2019 13F Holders as of 31 Mar 2019
-
Type / Class
-
Equity / Common Stock, par value $0.0001 per share
-
Shares outstanding
-
22,278,088
-
Total 13F shares
-
7,474,791
-
Share change
-
+502,858
-
Total reported value
-
$527,055,463
-
Put/Call ratio
-
44%
-
Price per share
-
$70.54
-
Number of holders
-
180
-
Value change
-
+$37,891,180
-
Number of buys
-
87
-
Number of sells
-
66
Institutional Holders of ANI PHARMACEUTICALS INC - Common Stock, par value $0.0001 per share (ANIP) as of Q1 2019
As of 31 Mar 2019,
ANI PHARMACEUTICALS INC - Common Stock, par value $0.0001 per share (ANIP) was held by
180 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
7,474,791 shares.
The largest 10 holders included
BlackRock Inc., VANGUARD GROUP INC, MANGROVE PARTNERS, DIMENSIONAL FUND ADVISORS LP, NOMURA HOLDINGS INC, INVESTMENT COUNSELORS OF MARYLAND LLC, STATE STREET CORP, FIRST MANHATTAN CO, RENAISSANCE TECHNOLOGIES LLC, and Consonance Capital Management LP.
This page lists
181
institutional shareholders reporting positions in this security
for the Q1 2019 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.